cell-based potency assays

Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cellular therapy market. It was the first company to successfully develop and commercialize an immunotherapy made from a patient's own cells, gaining FDA approval for PROVENGE (sipuleucel-T) in 2010, which has been prescribed to nearly 40,000 men with advanced prostate cancer.

Read more

apheresis managementautologous and allogeneic cell therapy manufacturingcellular therapy manufacturingcGMP manufacturingclinical and regulatory supportendotoxin testingFlow Cytometrylogistics and delivery of time-critical therapiesPCRprocess and analytical developmentquality control testing